Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation | |
---|---|---|
drug3468 | SCTA01 Wiki | 1.00 |
drug3464 | SCB-2019 with AS03 adjuvant Wiki | 1.00 |
drug3465 | SCB-2019 with CpG 1018 adjuvant plus Alum adjuvant Wiki | 1.00 |
Name (Synonyms) | Correlation |
---|
Navigate: Correlations HPO
There is one clinical trial.
This is a randomized, double blind, placebo controlled, first-in-human (FIH) study to assess safety, reactogenicity, and immunogenicity of SCB-2019 at multiple dose levels, administered as 2 injections IM in healthy subjects. Each study vaccine dose level will be evaluated with and without adjuvant.
Description: Geometric mean titer (GMT). Geometric mean ratio (GMR). Seroconversion rate (SCR).
Measure: Immunogenicity(Anti-SCB-2019 Antibody Titers) Time: Day 1 to Day 184Description: Geometric mean titer (GMT). Geometric mean ratio (GMR). Seroconversion rate (SCR).
Measure: Immunogenicity( serum anti SARS-CoV-2 neutralizing antibody titers (ACE2 receptor-based) ) Time: Day 1 to Day 184Description: Geometric mean titer (GMT). Geometric mean ratio (GMR). Seroconversion rate (SCR).
Measure: Immunogenicity(serum anti SARS-CoV-2 neutralizing antibody titers (cell based) ) Time: Day 1 to Day 184Description: Geometric mean titer (GMT). Geometric mean ratio (GMR). Seroconversion rate (SCR).
Measure: Immunogenicity(serum anti SARS-CoV-2 whole virus antibody titers) Time: Day 1 to Day 184Description: Geometric mean titer (GMT). Geometric mean ratio (GMR). Seroconversion rate (SCR).
Measure: Antibody kinetics of each SCB 2019 vaccine formulation after first and second doses Time: Day 1 to Day 184Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports